Header

UZH-Logo

Maintenance Infos

Intermittent high-dose intravenous interferon Alfa-2b for adjuvant treatment of stage III melanoma: Final analysis of a randomized phase III dermatologic cooperative oncology group trial


Mohr, P; Hauschild, A; Trefzer, U; Enk, A; Tilgen, W; Loquai, C; Gogas, H; Haalck, T; Koller, J; Dummer, R; Gutzmer, R; Brockmeyer, N; Holzle, E; Sunderkotter, C; Mauch, C; Stein, A; Schneider, L A; Podda, M; Goppner, D; Schadendorf, D; Weichenthal, M (2015). Intermittent high-dose intravenous interferon Alfa-2b for adjuvant treatment of stage III melanoma: Final analysis of a randomized phase III dermatologic cooperative oncology group trial. Journal of Clinical Oncology, 33(34):4077-4084.

Statistics

Citations

7 citations in Web of Science®
6 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

2 downloads since deposited on 18 Dec 2015
0 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Dermatology Clinic
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:2015
Deposited On:18 Dec 2015 12:46
Last Modified:05 Apr 2016 19:40
Publisher:American Society of Clinical Oncology
ISSN:0732-183X
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:https://doi.org/10.1200/JCO.2014.59.6932

Download